TY - JOUR
T1 - Effect of propionic and methylmalonic acids on the in vitro phosphorylation of intermediate filaments from cerebral cortex of rats during development
AU - De Almeida, Lúcia Maria Vieira
AU - Funchal, Cláudia
AU - De Lima Pelaez, Priscila
AU - Dall Bello Pessutto, Franciele
AU - Oliveira Loureiro, Samanta
AU - Vivian, Lilian
AU - Wajner, Moacir
AU - Pessoa-Pureur, Regina
N1 - Funding Information:
This work was supported by Conselho Nacional de Desenvolvimento Científico e Tec-nológico(CNPq),Coordenac¸ãodeAperfeic¸oamentodePessoaldeNívelSuperior(CAPES), Fundac¸ão de Amparo à Pesquisa do Estado do Rio Grande do Sul (FAPERGS), and Pró-Reitoria de Pesquisa e Pós-Graduac¸ão da Universidade Federal do Rio Grande do Sul (PROPESq-UFRGS).
PY - 2003/9
Y1 - 2003/9
N2 - In this study we investigated the in vivo and in vitro effects of methylmalonic (MMA) and propionic acids (PA), at concentrations usually found in methylmalonic acidemia and propionic acidemia respectively, on the phosphorylation of intermediate filament proteins in cerebral cortex of rats during development. Rats of 9, 12, and 17 days were acutely injected with the acids and sacrificed 90 min after injection. The cerebral cortex was dissected, and slices were incubated with 32P-orthophosphate. The cytoskeletal fraction was extracted and the radioactivity incorporated into intermediate filament subunits was measured. In addition, cortical slices from nontreated rats of 9, 12, 15, 17, 21, and 60 days of life were incubated with the acids in the presence of 32P-orthophosphate, the cytoskeletal fraction was extracted and the radioactivity was measured. Results demonstrated that MMA and PA significantly decreased the radioactivity incorporated into intermediate filament proteins at day 12, both in vivo and in tissue slices. In contrast, PA increased the in vitro phosphorylation of the cytoskeletal proteins in slices of 21-day-old animals. It acts through PP2A and PP2B in 12-day-old rats and through PKA and PKCaMII in 21-day-old animals. We propose that alteration of cytoskeletal protein phosphorylation caused by methylmalonic and propionic acids may be related to the neurological dysfunction characteristic of propionic and methylmalonic acidemia.
AB - In this study we investigated the in vivo and in vitro effects of methylmalonic (MMA) and propionic acids (PA), at concentrations usually found in methylmalonic acidemia and propionic acidemia respectively, on the phosphorylation of intermediate filament proteins in cerebral cortex of rats during development. Rats of 9, 12, and 17 days were acutely injected with the acids and sacrificed 90 min after injection. The cerebral cortex was dissected, and slices were incubated with 32P-orthophosphate. The cytoskeletal fraction was extracted and the radioactivity incorporated into intermediate filament subunits was measured. In addition, cortical slices from nontreated rats of 9, 12, 15, 17, 21, and 60 days of life were incubated with the acids in the presence of 32P-orthophosphate, the cytoskeletal fraction was extracted and the radioactivity was measured. Results demonstrated that MMA and PA significantly decreased the radioactivity incorporated into intermediate filament proteins at day 12, both in vivo and in tissue slices. In contrast, PA increased the in vitro phosphorylation of the cytoskeletal proteins in slices of 21-day-old animals. It acts through PP2A and PP2B in 12-day-old rats and through PKA and PKCaMII in 21-day-old animals. We propose that alteration of cytoskeletal protein phosphorylation caused by methylmalonic and propionic acids may be related to the neurological dysfunction characteristic of propionic and methylmalonic acidemia.
KW - Cerebral cortex
KW - Development
KW - Intermediate filaments
KW - Methylmalonic acid
KW - Phosphorylation
KW - Propionic acid
UR - http://www.scopus.com/inward/record.url?scp=0141840780&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0141840780&partnerID=8YFLogxK
U2 - 10.1023/A:1025555132675
DO - 10.1023/A:1025555132675
M3 - Article
C2 - 14567471
AN - SCOPUS:0141840780
VL - 18
SP - 207
EP - 219
JO - Metabolic Brain Disease
JF - Metabolic Brain Disease
SN - 0885-7490
IS - 3
ER -